CTS vs TECH
CTS Corporation (CTS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
CTS Corporation (CTS) is a electronic components company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CTS revenue for 2025-12-31 was $541.3M. Net income was $65.3M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CTS currently screens at market cap $1.30B and trailing P/E 22.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CTS currently screens at market cap $1.30B and trailing P/E 22.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CTS and TECH stock pages for the full models.
Not investment advice.